The ITLN1 levels were significantly lower in gastric cancer cases with poor differentiation (P = 0.019), deeper gastric wall invasion (P < 0.001), lymph node metastasis (P < 0.001), and advanced tumor-node-metastasis (TNM) stage (P = 0.001) (Table S2). This evidence concerns the gene ITLN1 and gastric cancer.